Regulation of Transforming Growth Factor β-Activated Kinase Activation by Epigallocatechin-3-Gallate in Rheumatoid Arthritis Synovial Fibroblasts: Suppression of K63-Linked Autoubiquitination of Tumor Necrosis Factor Receptor-Associated Factor 6
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Regulation of Transforming Growth Factor β-Activated Kinase Activation by Epigallocatechin-3-Gallate in Rheumatoid Arthritis Synovial Fibroblasts: Suppression of K63-Linked Autoubiquitination of Tumor Necrosis Factor Receptor-Associated Factor 6
Authors
Keywords
-
Journal
Arthritis & Rheumatology
Volume 68, Issue 2, Pages 347-358
Publisher
Wiley
Online
2015-10-17
DOI
10.1002/art.39447
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interleukin-1 receptor associated kinase inhibitors: Potential therapeutic agents for inflammatory- and immune-related disorders
- (2015) Malkeet Singh Bahia et al. CELLULAR SIGNALLING
- TAK1 selective inhibition: state of the art and future opportunities
- (2015) Iain Kilty et al. Future Medicinal Chemistry
- Small-molecule therapeutics in rheumatoid arthritis: Scientific rationale, efficacy and safety
- (2014) Florian M.P. Meier et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- Interleukin 1/Toll-like Receptor-induced Autophosphorylation Activates Interleukin 1 Receptor-associated Kinase 4 and Controls Cytokine Induction in a Cell Type-specific Manner
- (2014) Leah Cushing et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases
- (2014) James D. Clark et al. JOURNAL OF MEDICINAL CHEMISTRY
- Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes?
- (2013) James A Nathan et al. EMBO JOURNAL
- IRAK-M mediates Toll-like receptor/IL-1R-induced NFκB activation and cytokine production
- (2013) Hao Zhou et al. EMBO JOURNAL
- Treating inflammation by blocking interleukin-1 in humans
- (2013) Charles A. Dinarello et al. SEMINARS IN IMMUNOLOGY
- Cell type-specific function of TAK1 in innate immune signaling
- (2013) Adebusola A. Ajibade et al. TRENDS IN IMMUNOLOGY
- Mechanism and In Vitro Pharmacology of TAK1 Inhibition by (5Z)-7-Oxozeaenol
- (2012) Jiaquan Wu et al. ACS Chemical Biology
- Ubiquitination in signaling to and activation of IKK
- (2012) Zhijian J. Chen IMMUNOLOGICAL REVIEWS
- Anakinra as an interleukin 1 receptor antagonist, complicated genetics and molecular impacts- from the point of view of mouse genomics
- (2012) Yanhong Cao et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- TAK1, more than just innate immunity
- (2012) Liang Dai et al. IUBMB LIFE
- -TrCP-Mediated IRAK1 Degradation Releases TAK1-TRAF6 from the Membrane to the Cytosol for TAK1-Dependent NF- B Activation
- (2012) W. Cui et al. MOLECULAR AND CELLULAR BIOLOGY
- Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors
- (2012) Nunzio Bottini et al. Nature Reviews Rheumatology
- Kinase Inhibition — A New Approach to the Treatment of Rheumatoid Arthritis
- (2012) David A. Fox NEW ENGLAND JOURNAL OF MEDICINE
- Targeting of TAK1 in inflammatory disorders and cancer
- (2012) Hiroaki Sakurai TRENDS IN PHARMACOLOGICAL SCIENCES
- Cadherin-11 regulates fibroblast inflammation
- (2011) S. K. Chang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- In vivo RNAi-mediated silencing of TAK1 decreases inflammatory Th1 and Th17 cells through targeting of myeloid cells
- (2010) G. Courties et al. BLOOD
- Down-regulation of myeloid cell leukemia 1 by epigallocatechin-3-gallate sensitizes rheumatoid arthritis synovial fibroblasts to tumor necrosis factor α-induced apoptosis
- (2009) Salahuddin Ahmed et al. ARTHRITIS AND RHEUMATISM
- Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis
- (2009) Beatrix Bartok et al. IMMUNOLOGICAL REVIEWS
- The kinase activities of interleukin-1 receptor associated kinase (IRAK)-1 and 4 are redundant in the control of inflammatory cytokine expression in human cells
- (2009) Kyung W. Song et al. MOLECULAR IMMUNOLOGY
- Breaking the chains: structure and function of the deubiquitinases
- (2009) David Komander et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The Risk of Infections with Biologic Therapies for Rheumatoid Arthritis
- (2009) Daniel E. Furst SEMINARS IN ARTHRITIS AND RHEUMATISM
- Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials
- (2008) C Salliot et al. ANNALS OF THE RHEUMATIC DISEASES
- Phosphorylation of Thr-178 and Thr-184 in the TAK1 T-loop Is Required for Interleukin (IL)-1-mediated Optimal NFκB and AP-1 Activation as Well as IL-6 Gene Expression
- (2008) Yang Yu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The type I TGF-β receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner
- (2008) Alessandro Sorrentino et al. NATURE CELL BIOLOGY
- Epigallocatechin-3-gallate inhibits IL-6 synthesis and suppresses transsignaling by enhancing soluble gp130 production
- (2008) S. Ahmed et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now